[go: up one dir, main page]

HK1009584A1 - Therapeutic preparation for inhalation - Google Patents

Therapeutic preparation for inhalation Download PDF

Info

Publication number
HK1009584A1
HK1009584A1 HK98110295A HK98110295A HK1009584A1 HK 1009584 A1 HK1009584 A1 HK 1009584A1 HK 98110295 A HK98110295 A HK 98110295A HK 98110295 A HK98110295 A HK 98110295A HK 1009584 A1 HK1009584 A1 HK 1009584A1
Authority
HK
Hong Kong
Prior art keywords
insulin
preparation
therapeutic preparation
particles
active compounds
Prior art date
Application number
HK98110295A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1009584B (en
Inventor
Goran Erik Backstrom Kjell
Magnus Olof Dahlback Carl
Edman Peter
Charlottee Birgit Johansson Ann
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9302198A external-priority patent/SE9302198D0/xx
Priority claimed from SE9400370A external-priority patent/SE9400370L/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HK1009584A1 publication Critical patent/HK1009584A1/en
Publication of HK1009584B publication Critical patent/HK1009584B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK98110295.4A 1993-06-24 1994-06-23 Therapeutic preparation for inhalation HK1009584B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9302198A SE9302198D0 (sv) 1993-06-24 1993-06-24 Powder preparation for inhalation
SE9302198 1993-06-24
SE9400370 1994-02-04
SE9400370A SE9400370L (sv) 1994-02-04 1994-02-04 Terapeutisk komposition för inhalation
PCT/SE1994/000633 WO1995000127A1 (en) 1993-06-24 1994-06-23 Therapeutic preparation for inhalation

Publications (2)

Publication Number Publication Date
HK1009584A1 true HK1009584A1 (en) 1999-06-04
HK1009584B HK1009584B (en) 2000-04-14

Family

ID=

Also Published As

Publication number Publication date
JP3874789B2 (ja) 2007-01-31
IL110084A (en) 1999-07-14
FI111688B (fi) 2003-09-15
SK160195A3 (en) 1997-02-05
CA2166108A1 (en) 1995-01-05
EG20599A (en) 1999-09-30
CN1110301C (zh) 2003-06-04
HU9503659D0 (en) 1996-02-28
JPH08512027A (ja) 1996-12-17
GR3031974T3 (en) 2000-03-31
MY112098A (en) 2001-04-30
SA94150030B1 (ar) 2006-04-04
NO955226L (no) 1996-02-15
IS4178A (is) 1994-12-25
CN1129904A (zh) 1996-08-28
PL178403B1 (pl) 2000-04-28
NO313657B1 (no) 2002-11-11
KR100372673B1 (ko) 2003-05-12
DE69420412T2 (de) 2000-04-13
MX9404761A (es) 1995-01-31
BR9406907A (pt) 1996-04-02
UA49794C2 (uk) 2002-10-15
AU7090194A (en) 1995-01-17
FI956227L (fi) 1995-12-22
ATE183920T1 (de) 1999-09-15
JP2006089496A (ja) 2006-04-06
IS1768B (is) 2001-05-02
CZ287314B6 (en) 2000-10-11
FI956227A0 (fi) 1995-12-22
US5658878A (en) 1997-08-19
HUT75065A (en) 1997-03-28
HU228129B1 (en) 2012-12-28
WO1995000127A1 (en) 1995-01-05
SK283145B6 (sk) 2003-03-04
US5518998C1 (en) 2001-02-13
EE03221B1 (et) 1999-10-15
CA2166108C (en) 2008-10-21
US5518998A (en) 1996-05-21
NO955226D0 (no) 1995-12-21
US6306440B1 (en) 2001-10-23
RU2148398C1 (ru) 2000-05-10
CZ342895A3 (en) 1996-05-15
DK0706382T3 (da) 2000-03-13
EP0706382A1 (en) 1996-04-17
EP0706382B1 (en) 1999-09-01
PL312205A1 (en) 1996-04-01
NZ268137A (en) 1997-10-24
JP4294635B2 (ja) 2009-07-15
DE69420412D1 (de) 1999-10-07
IL110084A0 (en) 1994-10-07
AU692780B2 (en) 1998-06-18
TW402506B (en) 2000-08-21
ES2138087T3 (es) 2000-01-01

Similar Documents

Publication Publication Date Title
EP0706382B1 (en) Therapeutic preparation for inhalation
US5747445A (en) Therapeutic preparation for inhalation
US6165976A (en) Therapeutic preparation for inhalation
US5506203A (en) Systemic administration of a therapeutic preparation
US6846801B1 (en) Systemic administration of a therapeutic preparation
US5952008A (en) Processes for preparing compositions for inhalation
US6794357B1 (en) Compositions for inhalation
US6632456B1 (en) Compositions for inhalation
US20030216541A1 (en) Systemic administration of a therapeutic preparation
HK1009584B (en) Therapeutic preparation for inhalation
US20010025037A1 (en) Systemic administration of a therapeutic preparation
NZ328475A (en) A pharmaceutical composition containing a polypeptide up to 40 kD and an enhancer for systemic delivery by inhalation
LT3445B (en) Therapeutic preparation for inhalation

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120623